US 11484511
Pharmaceutical composition comprising THA as effective ingredient for treatment of prostate cancer
granted A61KA61K2236/331A61K31/12
Quick answer
US patent 11484511 (Pharmaceutical composition comprising THA as effective ingredient for treatment of prostate cancer) held by KOREA UNITED PHARM. INC. expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- KOREA UNITED PHARM. INC.
- Grant date
- Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K2236/331, A61K31/12, A61K31/135, A61K36/9066